Secondary Hypogammaglobulinemia
This article reviews immunosuppressive medications, including biological treatments that cause secondary hypogammaglobulinemia. It summarizes risk factors for rituximab-induced hypogammaglobulinemia, such as preexisting low immunoglobulin G levels, CD19 levels, host factors, and additive effect of all immunomodulatory drugs used. The evaluation and management of secondary hypogammaglobulinemia are discussed.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Blanka Kaplan, Vincent R. Bonagura Source Type: research
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Cancer & Oncology | Rituxan | Stem Cell Therapy | Stem Cells | Transplants